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Accuracy of electrocardiography in diagnosis of left
ventricular hypertrophy in arterial hypertension: systematic
review
Daniel Pewsner,1 Peter Ju¨ni,2 Matthias Egger,3 Markus Battaglia,1 Johan Sundstro¨m,4 Lucas M Bachmann5
ABSTRACT
Objective To review the accuracy of electrocardiography
in screening for left ventricular hypertrophy in patients
with hypertension.
DesignSystematic review of studies of test accuracy of six
electrocardiographic indexes: the Sokolow-Lyon index,
Cornell voltage index, Cornell product index, Gubner
index, and Romhilt-Estes scores with thresholds for a
positive test of ≥4 points or ≥5 points.
Data sources Electronic databases ((Pre-)Medline,
Embase), reference lists of relevant studies and previous
reviews, and experts.
Study selection Two reviewers scrutinised abstracts and
examined potentially eligible studies. Studies comparing
the electrocardiographic index with echocardiography in
hypertensive patients and reporting sufficient data were
included.
Data extraction Data on study populations,
echocardiographic criteria, andmethodological quality of
studies were extracted.
Data synthesis Negative likelihood ratios, which indicate
to what extent the posterior odds of left ventricular
hypertrophy is reduced by a negative test, were
calculated.
Results 21 studies and data on 5608 patients were
analysed. The median prevalence of left ventricular
hypertrophy was 33% (interquartile range 23-41%) in
primary care settings (10 studies) and 65% (37-81%) in
secondary care settings (11 studies). The median
negative likelihood ratio was similar across
electrocardiographic indexes, ranging from 0.85 (range
0.34-1.03) for the Romhilt-Estes score (with threshold
≥4 points) to 0.91 (0.70-1.01) for the Gubner index.
Using the Romhilt-Estes score in primary care, a
negative electrocardiogram result would reduce the
typical pre-test probability from 33% to 31%. In
secondary care the typical pre-test probability of 65%
would be reduced to 63%.
Conclusion Electrocardiographic criteria should not be
used to rule out left ventricular hypertrophy in patients
with hypertension.
INTRODUCTION
Left ventricular hypertrophy is an important risk
factor in patients with hypertension, leading to a
fivefold to 10-fold increase in cardiovascular risk.1-5
Decisions about treatment should be based on
assessments of hypertensive target organ damage
and overall cardiovascular risk. The appropriate
diagnostic work-up of suspected left ventricular
hypertrophy in patients with hypertension is less
clear, however. More than 30 electrocardiographic
indexes for the diagnosis of left ventricular hyper-
trophy have been described. Many of the proposed
indexes have remained anecdotal, but others are
commonly used.6-10 Debate about their comparative
diagnostic value continues.11-13 We did a systematic
review to clarify the accuracy of different electro-
cardiographic indexes.
This article is an abridged version
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METHODS
Identification of studies—We searched Medline from
1966 to December 2005 and Embase from 1980 to
December 2005 to identify observational studies that
evaluated the accuracy of electrocardiographic
indexes for the diagnosis of left ventricular hyper-
trophy and established the presence or absence of left
ventricular hypertrophy with echocardiography. We
checked reference lists of relevant studies and
contacted experts to complement electronic searches.
Study selection—We included studies in asymptomatic
patients with primary arterial hypertension in any
healthcare setting. Studies included patients taking anti-
hypertensive treatment, those being evaluated for
treatment, and patients in whom treatment was
withdrawn shortly before evaluation. Two reviewers
independently assessed the abstracts of all retrieved
studies.We included all studies that assessed the electro-
cardiographic criteria in hypertensive adults against
echocardiography.
Data extraction—We extracted data in duplicate,
including the number and characteristics of patients,
the healthcare setting, the prevalence of echocardio-
graphically confirmed left ventricular hypertrophy,
the electrocardiographic indexes evaluated, and the
definition of the echocardiography threshold.
Assessment of study quality—We assessed the method-
ological quality of papers. We examined the methods
of patient selection and data collection, completeness
of descriptions of index and reference tests,
completeness of blinding, and the likelihood of verifi-
cation bias.14-16 We ranked the quality of studies on the
basis of the following criteria: description of setting;
prospective data collection, with enrolment of
consecutive patients and follow-up of all patients; and
provisionof details on echocardiography andblinding.
Statistical analysis—Wecalculated sensitivities, speci-
ficities, and likelihood ratios with their confidence
intervals. As the electrocardiogram will mainly be
used to rule out the diagnosis of left ventricular hyper-
trophy, we were particularly interested in the
sensitivity and the likelihood ratio of a negative
electrocardiogram result. The likelihood ratio of a
negative test indicates how likely it is to find a negative
result among people with left ventricular hypertrophy
compared with those without.17 We summarised
results by plotting sensitivities and specificities in the
receiver operating curve space and by calculating
medians, ranges, and interquartile ranges.
RESULTS
Our search identified 1761 citations. We considered
142 as potentially eligible, and after scrutinising the
full text articles we included 21 studies.w1-w21
Study characteristics
The 21 studies included a total of 5608 (range 30-947)
patients. Ten studies were done in primary care and 11
in secondary care. The median prevalence of left
ventricular hypertrophy was 33% (interquartile range
23-41%) in primary care settings and 65% (37-81%) in
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Fig 1 | Forest plots of negative likelihood ratio from test accuracy studies of six
electrocardiographic indexes in diagnosis of left ventricular hypertrophy. Points represent
estimates of likelihood ratio; lines represent 95% confidence intervals
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secondary care.Three studiesmet all sixmethodological
criteria and were ranked as high quality. Another 11
studiesmet four or five criteria andwere ranked as inter-
mediate quality, whereas seven studies met two or three
quality criteria and were considered of low quality.
Electrocardiographic indexes
The 21 articles reported on 12 different electrocardio-
graphic criteria. We analysed in detail the six most
commonly used indexes, including the Sokolow-Lyon
voltage index,6 the Cornell voltage andCornell product
indexes,78 the Gubner index,9 and the Romhilt-Estes
scorewith thresholds for a positive test of≥4 points or≥5
points.10
Sensitivity, specificity, and likelihood ratios
For all indexes, most studies showed low sensitivity and
high specificity (see bmj.com). The median sensitivity
ranged from 10.5% (range 0-39%) for the Gubner
index to 21% (4-52%) for the Sokolow-Lyon index.
Median specificity ranged from 89% (53-100%) for the
Sokolow-Lyon index to 99% (71-100%) for the
Romhilt-Estes (five points) score.
Figures 1 and 2 show forest plots of the negative and
positive likelihood ratios. The median negative
likelihood ratio was similar across electrocardiographic
indexes, ranging from 0.85 (range 0.34-1.03) for the
Romhilt-Estes score (four points) to 0.91 (0.70-1.01) for
theGubner index.More variation existed in the positive
likelihood ratio, which ranged from 1.90 (0.16-25.9) for
the Sokolow-Lyon index to 5.90 (0.71-18.2) for the
Romhilt-Estes score (four points). Using the median
likelihood ratios from the Romhilt-Estes score (four
points) in primary care, a negative electrocardiogram
result would reduce the typical pre-test probability of
33% to 31%, whereas a positive electrocardiogram
would increase it to 74%. In secondary care, the typical
pre-test probability of 65% would be reduced to 63% or
increased to 92%.
DISCUSSION
This systematic review of studies of the accuracy of diag-
nostic tests found that the accuracy of electrocardio-
graphic indexes in the diagnosis of left ventricular
hypertrophy is unsatisfactory. Irrespective of the index
used, the electrocardiogram is a poor screening tool to
exclude left ventricular hypertrophy in hypertensive
patients. Of note, specificity was reasonably high in
most studies, but because sensitivity was low the power
to rule in left ventricular hypertrophy was also
unsatisfactory.
Strengths and limitations
We did a comprehensive literature search, selected
studies according to pre-defined criteria, and appraised
the methodological quality of studies. We excluded
diagnostic case-control studies, which are known to
overestimate accuracy,1415 as well as studies that did
not index ventricular mass for body surface area. We
also excluded studies that evaluated patients with
concomitant left anterior fascicular block and left bundle
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Fig 2 | Forest plots of positive likelihood ratio from test accuracy studies of six
electrocardiographic indexes in diagnosis of left ventricular hypertrophy. Points represent
estimates of likelihood ratio; lines represent 95% confidence intervals
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branch block, because these patients usually need
further examinations and referral irrespective of left
ventricular hypertrophy. We summarised the evidence
by calculating medians, rather than combining data in
meta-analysis. We believe that a formal meta-analysis
would have added little in this situation. We felt that
further exploration of potential sources of heterogeneity
was not warranted. The published data did not allow
direct comparisonsof test accuracybetween thedifferent
indexes. More importantly, we did not identify any
randomised comparisons of diagnostic and treatment
strategies and assessed clinical end points.
Implications for clinical practice
Electrocardiograms should not be done specifically to
exclude left ventricular hypertrophy in patients with
hypertension. Referral for specialist examinations is
often based on high cardiovascular risk scores, but
echocardiography may be more informative in hyper-
tensive patients who, on the basis of age, sex, smoking
history, and blood lipids, are at low or intermediate
risk. In patients known to be at high risk, echocardio-
graphic findings will often not affect clinical manage-
ment, because interventions to reduce risk are already
in place.
The evidence on the capacity of various anti-
hypertensive agents to decrease left ventricular hyper-
trophy is limited. Preventing cardiovascular disease
through modifications of other risk factors such as
smoking cessation, lifestyle change, or lipid lowering
treatment is the most promising approach.18 19
Future research
Further research is needed to identify cost effective
diagnostic strategies in primary care settings. Such
research could inform the development of algorithms
to identify patients who should be referred for echo-
cardiography. In the absence of accurate and
inexpensive screening tests for left ventricular hyper-
trophy, research into new diagnostic technologies is
also warranted. Further studies are needed to better
define the pathophysiological mechanisms and out-
comes in patients with echocardiographically
confirmed left ventricular hypertrophy but negative
electrocardiograms. Similarly, more data are needed
on patients with positive electrocardiographic tests
but negative echocardiography.
Conclusions
The power of some of the more commonly used elec-
trocardiographic criteria to rule out the diagnosis of left
ventricular hypertrophy in patients with hypertension
is poor. Further research is needed to assess the cost
effectiveness of different diagnostic and treatment stra-
tegies of left ventricular hypertrophy in primary care.
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WHAT IS ALREADY KNOWN ON THIS TOPIC
Left ventricular hypertrophy leads to a fivefold to 10-fold increase in cardiovascular risk in
hypertensive patients
Several indexes calculated from standard 12 lead electrocardiograms are used in the
diagnostic work-up of patients with hypertension
WHAT THIS STUDY ADDS
The accuracy of the more commonly used electrocardiographic criteria for ruling out left
ventricular hypertrophy is unsatisfactory in both primary and secondary care.
Echocardiography is needed for a comprehensive assessment of cardiovascular risk in
hypertensive patients
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